Literature DB >> 10358210

Induction of HIV-1 replication by allogeneic stimulation.

H Moriuchi1, M Moriuchi, A S Fauci.   

Abstract

Allogeneic stimulation presents an immunologic challenge during pregnancy, blood transfusions, and transplantations, and has been associated with reactivation of latently infected virus such as CMV. Since HIV-1 is transmitted vertically, sexually, or via contaminated blood, we have tested the effects of allostimulation on HIV-1 infection. 1) We show that allostimulated lymphocytes are highly susceptible to acute infection with T cell-tropic or dual-tropic HIV-1. 2) We show that allostimulation has dichotomous effects on replication of macrophage-tropic HIV-1; it activates HIV expression in already infected cells but inhibits HIV entry by secreting HIV-suppressive CC chemokines. 3) We show that allogeneic stimulation of latently infected, resting CD4+ T cells induced replication of HIV-1 in these cells. These observations suggest that allogeneic stimulation may play a role in the transmission, replication, and phenotypic transition of HIV-1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10358210

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Effect of latent human immunodeficiency virus infection on cell surface phenotype.

Authors:  David G Brooks; Jerome A Zack
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Cytokine responses to treponema pectinovorum and treponema denticola in human gingival fibroblasts.

Authors:  C S Nixon; M J Steffen; J L Ebersole
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

3.  Novel pathway for induction of latent virus from resting CD4(+) T cells in the simian immunodeficiency virus/macaque model of human immunodeficiency virus type 1 latency.

Authors:  Anding Shen; Hung-Chih Yang; Yan Zhou; Amanda J Chase; Jean D Boyer; Hao Zhang; Joseph B Margolick; M Christine Zink; Janice E Clements; Robert F Siliciano
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

4.  Suppressed cellular alloimmune responses in HIV-exposed seronegative female sex workers.

Authors:  W Jennes; D Evertse; M-Y Borget; B Vuylsteke; C Maurice; J N Nkengasong; L Kestens
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

5.  Fetal allostimulation of maternal cells: a potential mechanism for perinatal HIV transmission following obstetrical hemorrhage.

Authors:  Guangwu Wang; Nazanin Izadpanah; Christina M R Kitchen; Helene B Bernstein
Journal:  AIDS Res Hum Retroviruses       Date:  2008-12       Impact factor: 2.205

6.  Fetal cord blood mononuclear cells that are collected at term from HIV-1 infected women harbor transcriptionally active integrated proviral DNA.

Authors:  Jane E Ellis; Gregory A Hair; Michael K Lindsay; Aftab A Ansari; J Bruce Sundstrom
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

7.  Engagement of ICAM-3 provides a costimulatory signal for human immunodeficiency virus type 1 replication in both activated and quiescent CD4+ T lymphocytes: implications for virus pathogenesis.

Authors:  Corinne Barat; Philippe Gervais; Michel J Tremblay
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines.

Authors:  Yoshihiko Hoshino; Koh Nakata; Satomi Hoshino; Yoshihiro Honda; Doris B Tse; Tatsuo Shioda; William N Rom; Michael Weiden
Journal:  J Exp Med       Date:  2002-02-18       Impact factor: 14.307

9.  Modulation of susceptibility to HIV-1 infection by the cytotoxic T lymphocyte antigen 4 costimulatory molecule.

Authors:  J L Riley; K Schlienger; P J Blair; B Carreno; N Craighead; D Kim; R G Carroll; C H June
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

10.  New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.

Authors:  C Korin Bullen; Gregory M Laird; Christine M Durand; Janet D Siliciano; Robert F Siliciano
Journal:  Nat Med       Date:  2014-03-23       Impact factor: 53.440

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.